Lorcaserin Extended-Release Tablets and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Lorcaserin Extended-Release Tablets and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pneumococcal Conjugate Vaccine (7-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lorcaserin Extended-Release Tablets-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Lorcaserin Extended-Release Tablets-Pneumovax 23
- Lorcaserin Extended-Release Tablets-PNV - Omega
- Lorcaserin Extended-Release Tablets-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorcaserin Hydrochloride
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorcaserin Tablets
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorcet
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorcet Plus
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorcet Tablets
- Pneumococcal Conjugate Vaccine (13-Valent)-Lorlatinib